Showing results (1-10 of 27) with videos related to
Sort By:
Pageof 3
Case Reports in Vascular Medicine|August 13, 2013
Successful therapy of ventricular rupture by percutaneous intrapericardial instillation of fibrin glue: a case reportFlorian Willecke, Christoph Bode, Andreas ZirlikDrug Metabolism and Disposition: the Biological Fate of Chemicals|February 26, 2024
Enzymatic defluorination of a terminally monofluorinated pentyl moiety: oxidative or hydrolytic mechanism?Belal Haschimi, Florian Willecke, Stefan Mundinger, et al.Thrombosis and Haemostasis|June 4, 2009
Inhibition by fibrates of plasminogen activator inhibitor type-1 expression in human adipocytes and preadipocytesAndreas Zirlik, Sandra Ernst, Anne Leugers, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 31, 2025
The orexin 1-selective receptor antagonist nivasorexant is a time-dependent inhibitor of CYP2C19 and CYP3A4Alexander Treiber, Fabienne Drouet, Swen Seeland, et al.Plos One|June 6, 2015
Effects of High Fat Feeding and Diabetes on Regression of Atherosclerosis Induced by Low-Density Lipoprotein Receptor Gene Therapy in LDL Receptor-Deficient MiceFlorian Willecke, Chujun Yuan, Kazuhiro Oka, et al.Journal of Vascular Research|August 23, 2019
Tumor Necrosis Factor Receptor-Associated Factor 5 Promotes Arterial Neointima Formation through Smooth Muscle Cell ProliferationFlorian Willecke, Benjamin Rupprecht, Mark Colin Gissler, et al.Circulation Research|November 18, 2015
Cardiac Myocyte KLF5 Regulates Ppara Expression and Cardiac FunctionKonstantinos Drosatos, Nina M Pollak, Christine J Pol, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|November 15, 2014
Lipolysis, and not hepatic lipogenesis, is the primary modulator of triglyceride levels in streptozotocin-induced diabetic miceFlorian Willecke, Diego Scerbo, Prabhakara Nagareddy, et al.Scientific Reports|December 1, 2019
Glucose lowering by SGLT2-inhibitor empagliflozin accelerates atherosclerosis regression in hyperglycemic STZ-diabetic miceJan Pennig, Philipp Scherrer, Mark Colin Gissler, et al.Plos One|May 5, 2011
Cannabinoid receptor 2 signaling does not modulate atherogenesis in miceFlorian Willecke, Katharina Zeschky, Alexandra Ortiz Rodriguez, et al.Pageof 3